We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$14.6B
AUM Growth
-$824M
Cap. Flow
-$306M
Cap. Flow %
-2.09%
Top 10 Hldgs %
19.14%
Holding
138
New
3
Increased
38
Reduced
88
Closed
8

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$75.6M
2
TOST icon
Toast
TOST
+$47.6M
3
RGEN icon
Repligen
RGEN
+$46.1M
4
TW icon
Tradeweb Markets
TW
+$41M
5
WDAY icon
Workday
WDAY
+$34M

Sector Composition

Rank Sector Weight
1 Healthcare 22.55%
2 Technology 19.36%
3 Industrials 18.6%
4 Financials 14.82%
5 Consumer Staples 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATR icon
26
AptarGroup
ATR
$8.54B
$169M 1.15%
1,774,420
-37,850
-2% -$3.94M
GGG icon
27
Graco
GGG
$13B
$160M 1.09%
2,664,770
-53,700
-2% -$3.45M
MSA icon
28
Mine Safety
MSA
$6.73B
$159M 1.09%
1,458,060
-7,870
-0.5% -$968K
VEEV icon
29
Veeva Systems
VEEV
$32.7B
$159M 1.09%
966,246
+41,740
+5% +$8.34M
PEN icon
30
Penumbra
PEN
$12.6B
$152M 1.04%
804,075
+195,635
+32% +$31.4M
TNDM icon
31
Tandem Diabetes Care
TNDM
$1.3B
$149M 1.02%
3,123,973
+484,310
+18% +$26.6M
VRSK icon
32
Verisk Analytics
VRSK
$26.1B
$145M 0.99%
852,210
-17,815
-2% -$3.33M
JBTM
33
JBT Marel
JBTM
$7.31B
$144M 0.98%
1,677,055
+64,200
+4% +$6.81M
DXCM icon
34
DexCom
DXCM
$28.8B
$144M 0.98%
1,785,664
+275,086
+18% +$23.3M
CLX icon
35
Clorox
CLX
$11.7B
$143M 0.98%
1,116,770
-22,365
-2% -$3.23M
AQUA
36
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$139M 0.95%
4,196,530
-61,270
-1% -$2.22M
SJM icon
37
J.M. Smucker
SJM
$13.1B
$138M 0.94%
1,005,795
-187,165
-16% -$25.5M
TECH icon
38
Bio-Techne
TECH
$11.2B
$137M 0.94%
1,936,020
-38,360
-2% -$3.31M
NTRS icon
39
Northern Trust
NTRS
$22.4B
$133M 0.91%
1,556,940
-33,915
-2% -$3.27M
OKTA icon
40
Okta
OKTA
$24.4B
$132M 0.9%
2,322,407
+879,140
+61% +$75.6M
MASI
41
DELISTED
Masimo
MASI
$132M 0.9%
934,762
-16,980
-2% -$2.48M
MZTI
42
The Marzetti Company
MZTI
$2.95B
$131M 0.89%
868,808
-114,330
-12% -$17M
COO icon
43
Cooper Companies
COO
$14.2B
$130M 0.89%
1,968,220
+95,140
+5% +$7.29M
ASAN icon
44
Asana
ASAN
$1.83B
$130M 0.89%
5,834,769
+949,305
+19% +$20.4M
NEWR
45
DELISTED
New Relic, Inc.
NEWR
$126M 0.86%
2,188,500
-247,365
-10% -$14.8M
ULTA icon
46
Ulta Beauty
ULTA
$22.2B
$124M 0.85%
309,719
-7,410
-2% -$2.98M
TSCO icon
47
Tractor Supply
TSCO
$15.8B
$124M 0.85%
3,330,350
-62,300
-2% -$2.43M
SIVB
48
DELISTED
SVB Financial Group
SIVB
$123M 0.84%
365,416
+60,228
+20% +$24.2M
INSP icon
49
Inspire Medical Systems
INSP
$1.44B
$122M 0.84%
690,170
-8,415
-1% -$1.69M
WK icon
50
Workiva
WK
$3.29B
$122M 0.83%
1,569,480
+159,310
+11% +$10.9M

Similar funds

Champlain Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Champlain Investment Partners held 138 positions worth $14.6B, down 5.3% from $15.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners's Q3 2022 filing shows 3 new, 38 increased, 88 reduced and 8 closed positions. Its largest new stake was Toast: 2,747,085 shares worth $45.9M. The largest sale was Arthur J. Gallagher & Co, an estimated $119M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q3 2022 buy was Toast: 2,747,085 shares worth $45.9M.
  • Champlain Investment Partners added most to Okta in Q3 2022, an estimated $75.6M increase.
  • Champlain Investment Partners's biggest Q3 2022 reduction was Arthur J. Gallagher & Co, cutting an estimated $119M.
  • Champlain Investment Partners fully exited ZENDESK INC in Q3 2022, selling an estimated $95.8M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $14.6B portfolio in Q3 2022.
  • Champlain Investment Partners opened 3 new positions and closed 8 in Q3 2022.
  • Champlain Investment Partners's portfolio value fell 5.3% quarter-over-quarter to $14.6B.

Based on Champlain Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.